Schrodinger Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: $19.00 High: $19.81
on August 21, 2025

52 Week Range

Low: $16.60 High: $28.47
on April 7, 2025
on February 18, 2025

All-Time High: $117.00 on February 22, 2021

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $1.5B
EPS i -2.48
P/E Ratio (TTM) i 44.39
Forward P/E i -8.12
P/B Ratio i 4.30
PEG Ratio i -2.19
Div. Yield i N/A
ROE i -44.40%
Beta i 1.675
Debt to Equity i 33.38

Financial Highlights

Profitability

Gross Margin i 47.77%
Operating Margin i -96.61%
Profit Margin i -76.22%

Returns and Earnings

Return on Assets (TTM) i -17.52%
Return on Equity (TTM) i -44.40%
EBITDA i $-186.5M
Net Income (TTM) i $-181.3M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i $3.26
Quarterly Revenue Growth (YoY) i 15.70%
Quarterly Earnings Growth (YoY) i 15.69%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Schrodinger SDGR 1.48B Small-cap0.67%-14.20%-4.53%-13.52%-4.02%-1.46%-29.29%-68.26%
Veeva Systems VEEV 46.47B Large-cap2.65%0.46%20.12%25.02%34.05%41.67%36.70%3.00%
Ge Healthcare GEHC 33.48B Large-cap-0.69%-1.36%5.13%-19.69%-6.67%-13.72%28.92%28.92%
Certara CERT 1.80B Small-cap-1.82%6.21%-3.58%-18.22%1.03%-18.96%-34.73%-71.72%
10x Genomics TXG 1.68B Small-cap-1.06%13.52%57.45%20.18%-7.68%-44.23%-62.45%-88.12%
GoodRx Holdings GDRX 1.62B Small-cap26.84%-5.47%18.47%-6.65%-1.54%-45.44%-26.51%-91.37%

Ownership & Short Interest

Insider Ownership i 2.62%
Institutional Ownership i 108.61%
Shares Short i 9M
Short Ratio i 9.36
Short % of Shares Outstanding i 23.13%
Average 10-Day Volume i 2M
Average 90-Day Volume i 1M

Schrodinger Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Schrodinger would have performed over time.

$
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Schrodinger reached a high of $28.47 (on February 18, 2025) and a low of $16.60 (on April 7, 2025).
Curious about Schrodinger's size and valuation? Its market capitalization stands at 1.48B. When it comes to valuation, the P/E ratio (trailing twelve months) is 44.39, and the forward P/E (looking ahead) is -8.12.
As for dividends, Schrodinger isn't currently offering a significant yield, or that specific data isn't available right now.

When looking at Schrodinger, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Veeva Systems
VEEV
46.47BHealthcareHealth Information Services41.67%36.70%
Ge Healthcare
GEHC
33.48BHealthcareHealth Information Services-13.72%28.92%
Certara
CERT
1.80BHealthcareHealth Information Services-18.96%-34.73%
10x Genomics
TXG
1.68BHealthcareHealth Information Services-44.23%-62.45%
GoodRx Holdings
GDRX
1.62BHealthcareHealth Information Services-45.44%-26.51%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Schrodinger's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -44.40%, the Debt to Equity ratio from the most recent quarter is 33.38, and its Gross Profit Margin stands at 47.77%.
Looking at Schrodinger's growth, its revenue over the trailing twelve months (TTM) was $238M. Compared to the same quarter last year (YoY), quarterly revenue grew by 15.70%, and quarterly earnings saw a YoY growth of 15.69%.
Wondering who owns Schrodinger stock? Company insiders (like executives and directors) hold about 2.62% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 108.61%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.